VX-950 and Peginterferon for Hepatitis C
Clinical trial NCT00251199 · COMPLETED
Trial details
- NCT number
- NCT00251199
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.